The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a warning over a suspected case of tampering involving SMA Gold First Infant Milk Formula (900g tin) currently circulating in Kaduna State.
In a statement released through its Public Alert No. 06/2026 on Sunday, the 22nd of February, 2026, via its official X handle, the agency disclosed that a sample bearing batch number 22939510A1206, manufactured on 20-1-2025, was discovered with a fraudulently altered expiry date of 20-1-2027. The product, found on sale, carries NAFDAC registration number B1-2783 — a number assigned to the authentic SMA Gold 1 manufactured for the Nigerian market by Nestlé.
According to the agency:“The product allegedly caused gastrointestinal distress in a 4-month-old infant following consumption.
“Physical examination of the complaint product sample revealed clear indicators of date marking alteration.
“The manufacturing and expiry date on the top preprinted sticker was inconsistent with the underlying, originally printed version. This confirms the suspicion of revalidation and tampering,”
NAFDAC explained that SMA Gold Infant Formula is a whey-dominant formulation created to replicate the nutritional composition of breast milk for infants aged zero to six months. It emphasized that any unauthorized modification of expiry dates undermines product safety and may expose infants to serious health hazards.
The agency further warned that altering date markings distorts information about the product’s freshness and nutritional value.
“False dating misleads consumers regarding product freshness and nutritional integrity.
READ ALSO: PHOTOS: NAFDAC Uncovers Warehouse With Banned, Fake Cosmetics Worth Over ₦3bn In Lagos
“Expired infant formula may harbour microbial contamination and degraded nutrients, posing serious risks to vulnerable infants whose immune systems are still developing,”
As part of immediate regulatory action, NAFDAC has instructed all zonal directors and state coordinators nationwide to intensify market surveillance and withdraw the affected product wherever found.
The agency also urged distributors, retailers, medical practitioners, and caregivers to carefully confirm product authenticity, source products strictly from approved suppliers, and promptly flag any questionable or substandard items.
Members of the public and healthcare professionals are encouraged to report suspected cases or adverse reactions to the nearest NAFDAC office, through the Med-Safety app (available on Android and iOS), the E-reporting portal on the agency’s website, or via email at pharmacovigilance@nafdac.gov.ng.
NAFDAC reiterated its resolve to protect public health and ensure that all regulated products across Nigeria comply with established standards of quality, safety, and effectiveness.
